Evaluating the effectiveness of the clinical research radiographer undertaking the on-treatment review of clinical trial patients receiving radiotherapy for prostate cancer

Research output: Contribution to journalArticle

9 Downloads (Pure)

Abstract

Background
Radiotherapy clinical trials are at the forefront of modern-day prostate cancer patient management. Patients are reviewed during treatment by clinical oncologists or competent on-treatment review radiographers to minimise treatment toxicities. Clinical Research Radiographers (CRRs) routinely monitor and gather research data from patients participating in clinical trials.

Purpose
The aim of this article is to evaluate the effectiveness of the CRR undertaking the on-treatment review of clinical trial patients.

Method
An experienced CRR within the Northern Ireland Cancer Trials Network was supervised by a clinical oncologist to undertake the role of the on-treatment review of patients receiving radiotherapy for prostate cancer. The CRR explored published literature and compiled this written evaluation as part of their advanced practice learning.

Results
The supervising clinical oncologist verified, following the planned period of supervised practice and academic study, that the CRR was competent to fulfil the role. Evidence of the beneficial synergistic impact of co-joining the roles was experienced at first hand during the undertaking of supervised practice.

Conclusion
Co-joining the roles and responsibilities of the CRR and the on-treatment review radiographer enhanced the quality of care offered to the patients participating in clinical trials.
Original languageEnglish
Pages (from-to)123-126
Number of pages4
JournalJournal of Radiotherapy in Practice
Volume18
Issue number2
Early online date11 Dec 2018
DOIs
Publication statusPublished - 1 Jun 2019

Keywords

  • Clinical Research Radiographer (CRR)
  • clinical trials
  • Prostate cancer
  • radiotherapy
  • radiographer review
  • prostate cancer

Fingerprint Dive into the research topics of 'Evaluating the effectiveness of the clinical research radiographer undertaking the on-treatment review of clinical trial patients receiving radiotherapy for prostate cancer'. Together they form a unique fingerprint.

Cite this